Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...

Gregory, J.M. (2026) Alzheimer’s Disease: Modeling the Effect of Daily Steps . Journal of Behavioral and Brain Science, 16, ...

Asundexian cut the risk of an additional stroke by 26% in a large Phase 3 trial without accompanying safety issues, boosting the commercial outlook for an emerging class of anti-clotting drugs.

Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...

A report to NHS Ayrshire and Arran Health Board reveals 'deep pockets' of deprivation when it comes to child poverty.

Use of SGLT2 inhibitors was associated with lower 5-year risk for chronic kidney disease and AKI compared with GLP-1 receptor ...

Horoscope Today February 06, 2026, Friday: Market sentiment today leans towards cautious optimism, with investors weighing mixed economic data against ongoing rate expectations. This financial ...

Crypto market sentiment has fallen to extreme fear levels, with ETF data showing accelerating outflows, reinforcing a broader ...

Following the January FOMC meeting, the Federal Reserve held the policy rate unchanged at 3.50%–3.75%. Read more here.

Lower tariffs may revive India’s role in global sourcing, but the still-unratified deal underscores how fragile fashion’s ...

CMS Energy Corporation (NYSE:CMS) Q4 2025 Earnings Call Transcript February 5, 2026 CMS Energy Corporation beats earnings ...

After briefly holding above psychologically important levels, bitcoin slipped sharply, catching many investors off guard and triggering widespread ...